%0 Journal Article %1 Brendel.2006b %A Brendel, K. %A Comets, E. %A Laffont, C. %A Laveille, C. %A Mentre, F. %D 2006 %J PHARMACEUTICAL RESEARCH %K DEVELOPMENT DRUG MODIFIED PERFORMANCE PREDICTIVE RELEASE Simulation VALIDATION check evaluation external metrics model pharmacokinetics population posterior predictive validation %N 9 %P 2036-2049 %T Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide %V 23 %X Purpose. The aim of this study is to define and illustrate metrics for the external evaluation of a population model. Materials and Methods. In this paper, several types of metrics are defined: based on observations (standardized prediction error with or without simulation and normalized prediction distribution error); based on hyperparameters (with or without simulation); based on the likelihood of the model. All the metrics described above are applied to evaluate a model built from two phase II studies of gliclazide. A real phase I dataset and two datasets simulated with the real dataset design are used as external validation datasets to show and compare how metrics are able to detect and explain potential adequacies or inadequacies of the model. Results. Normalized prediction errors calculated without any approximation, and metrics based on hyperparameters or on objective function have good theoretical properties to be used for external model evaluation and showed satisfactory behav

@article{Brendel.2006b, abstract = {Purpose. The aim of this study is to define and illustrate metrics for the external evaluation of a population model. Materials and Methods. In this paper, several types of metrics are defined: based on observations (standardized prediction error with or without simulation and normalized prediction distribution error); based on hyperparameters (with or without simulation); based on the likelihood of the model. All the metrics described above are applied to evaluate a model built from two phase II studies of gliclazide. A real phase I dataset and two datasets simulated with the real dataset design are used as external validation datasets to show and compare how metrics are able to detect and explain potential adequacies or inadequacies of the model. Results. Normalized prediction errors calculated without any approximation, and metrics based on hyperparameters or on objective function have good theoretical properties to be used for external model evaluation and showed satisfactory behav}, added-at = {2010-02-04T16:31:48.000+0100}, author = {Brendel, K. and Comets, E. and Laffont, C. and Laveille, C. and Mentre, F.}, biburl = {https://www.bibsonomy.org/bibtex/28e77ec3b30c35f65554e08b218f841bc/hruehs}, interhash = {cd8fc89da5fa33ad50a23c294c502eac}, intrahash = {8e77ec3b30c35f65554e08b218f841bc}, issn = {0724-8741}, journal = {PHARMACEUTICAL RESEARCH}, keywords = {DEVELOPMENT DRUG MODIFIED PERFORMANCE PREDICTIVE RELEASE Simulation VALIDATION check evaluation external metrics model pharmacokinetics population posterior predictive validation}, number = 9, pages = {2036-2049}, timestamp = {2010-02-04T16:31:49.000+0100}, title = {Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide}, volume = 23, year = 2006 }